Martin Edwards, Director at Verona Pharma plc (VRNA), sold 13,688 shares at $0.99 ($14K) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Scheduled sale ($14k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MORF | BUY | 2023-11-15 | $49K | — | Filing → |
| VRNA | SELL | 2021-05-05 | $10K | — | Filing → |